Identification of a costimulatory molecule rapidly induced by CD40L as CD44H

Journal of Experimental Medicine

Volumn 184, Issue 3, 1996, Pages 955-961

  Guo, Yong ^a,d   Wu, Yan ^a   Shinde, Sanjay ^a   Sy, Man Sun ^b   Aruffo, Alejandro ^c   Liu, Yang ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; HERMES ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CHO CELL; CONTROLLED STUDY; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0029787322     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.3.955     Document Type: Article

References (47)

1. Foy, T.M., A. Aruffo, J.A. Ledbetter, P.S. Linsley, M. Kehry, and R. Noelle. 1995. Studies on the interdependency of gp39 and B7 expression and function during antigen-specific immune response. Eur. J. Immunol. 25:596-603.
2. Allen, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt, N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, D.K. Simoneaux et al. 1993. CD40 ligand gene defects responsible for the X-linked hyper IgM syndrome. Science (Wash. DC). 259:539-541.
3. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, R. Stemkamp, M. Neubauer, R.L. Robert et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patient with X-linked hyper IgM syndrome. Cell. 72:291-300.
4. DiSanto, J.P., J.Y. Bonefoy, J.F. Gauchat, A. Fisher, and G. de Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper IgM. Nature (Lond.). 361:541-544.
5. Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, F.S. Rosen, T. Chatila, S.-M. Fu, I. Stamenkovic, and R.S. Geha. 1993. Defective expression of T cell CD40 ligand in X-chromosome-linked immunoglobulin deficiency with normal and elevated IgM. Proc. Natl. Acad. Sci. USA. 90:2170-2174.
6. Foy, T.M., J.D. Laman, J.A. Ledbetter, A. Aruffo, E. Claassen, and R.J. Noelle. 1994. gp39-CD40 interaction is essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157-165.
7. Gray, D., P. Dullforce, and S. Jainandunsing. 1994. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction. J. Exp. Med. 180:141-155.
8. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliot, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R. Noelle, and R.A. Flavell. 1994. Mice deficient for CD40 ligand. Immunity. 1:423-431.
9. Grewal, I.S., J. Xu, and R.A. Flavell. 1995. Impairment of antigen-specific priming in mice lacking CD40 ligand. Nature (Lond.). 378:617-620.
10. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand transduced costimulation of T cells in the development of T helper function. Nature (Lond.). 378: 620-623.
11. Clark, E.A., and J.A. Ledbetter. 1994 How B and T cells talk to each other? Nature (Lond.). 367:425-428.
12. Liu, Y., and A. Müllbacher. 1989. Hypothesis: Immunological help must be delivered reciprocally among different sub-populations of lymphocytes. Scand. J. Immunol. 30:277-283.
13. Liu, Y. 1994. The costimulatory pathway for T cell responses. R.G. Landes Company, Austin, TX, 122 pp.
14. Liu, Y., and P.S. Linsley. 1992. Costimulation for T cell growth. Curr. Opin. Immunol. 4:265-270.
15. Mueller, D.L., M.K. Jenkins, and R.H. Schwartz. 1989. Clonal expansion vs functional clonal inactivation. A costimulatory signaling pathway determines the outcome of T cell receptor occupancy. Annu. Rev. Immunol. 7:445-480.
16. Lafferty, K.J., S.J. Prowse, and C.J. Simeonovich. 1983. Immunobiology of tissue transplantation: a return to passenger leukocyte concept. Annu. Rev. Immunol. 1:143-174.
17. Jenkins, M.K., and J.G. Johnson. 1993. Molecules involved in T cell costimulation. Curr. Opin. Immunol. 5:561-567.
18. Buhlmann, J.E., T.M. Foy, A. Aruffo, K.M. Crassi, J.A. Ledbetter, W.R. Green, J.C. Xu, L.D. Shultz, R.A. Falvell, L. Fast et al. 1995. In the absence of CD40 ligand, B cells are tolerogenic. Immunity. 2:645-653.
19. Wu, Y., J. Xu, S. Shinde, I. Grewal, T. Henderson, R.A. Flavell, and Y. Liu. 1995. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr. Biol. 5: 1303-1311.
20. Kennedy, M.K., K.M. Mohler, K.D. Shanebeck, P.R. Baum, K.S. Picha, C.A. Otten-Evans, C.A. Janeway, Jr, and K.H. Grabstein. 1994. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol. 24: 116-123.
21. Ranheim, E.A., and T.J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925-935.
22. Schultz, J.L., A.A. Cardoso, G.J. Freeman, M.J. Simon, J. Daley, G.S. Pinkus, J.G. Gribben, and L.M. Nadler. 1995. Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proc. Natl. Sci. USA. 92:8200-8204.
23. Shahinian, A., K. Pfeffer, K.P. Lee, T.M. Kundig, K. Kishihara, A. Wakham, K. Kawai, P.S. Ohashi, C.B. Thompson, and T.W. Mak. 1993. Differential costimulation requirement in CD28-deficient mice. Science (Wash. DC). 261:609-612.
24. Wu, Y., Y. Guo, and Y. Liu. 1993. A major costimulatory molecule, CTLA4 ligand A, is distinct from B7. J. Exp. Med. 178:1789-1793.
25. Guo, Y., Y. Wu, M. Zhao, X.P. Kong, and Y. Liu. 1995. Mutational analysis of an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain. J. Exp. Med. 181:1345-1355.
26. Leo, O., M. Foo, D.H. Sachs, L.E. Samelson, and J.A. Bluestone. 1987. Identification of a monoclonal antibody against murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84:1037-1041.
27. Metlay, J.P., M.D. Witmer-Pack, R. Agger, M.T. Crowley, D.S. Lawless, and R.M. Steinman. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171: 1753-1771.
28. Seed, B., and A. Aruffo. 1987. Molecular cloning of the CD2 antigen, the T cell erythrocyte receptor by rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA. 84:3365-3369.
29. Aruffo, A., I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1303-1313.
30. Budd, R.C., J.C. Cerottini, C. Horvath, C. Bron, T. Pedrazzini, R.C. Howe, and H.R. MacDonald. 1987. Distinction of virgin vs memory lymphocytes. Stable acquisition of the Pgp-1 glycoprotein expressed concomitant with antigenic stimulation. J. Immunol. 138:3120-3127.
31. Liu, D., and M.-S. Sy. 1996. A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid. J. Exp. Med. 183:1987-1994.
32. Green, J.M., P.J. Noel, A.I. Sperling, T.L. Walunas, G.S. Gray, J.A. Bluestone, and C.B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1:501-508.
33. Lesley, J., R. Hyman, and P.W. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271-335.
34. Hathcock, K.S., H. Hirano, S. Murakami, and R.J. Hodes. 1993. Cd44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid. J. Immunol. 151:6712-6722.
35. Rothman, B.L., M.L. Blue, K.A. Kelley, D. Wunderlich, D.V. Mierz, and T.M. Aune. 1991. Human T cell activation by OKT3 is inhibited by a monoclonal antibody to anti-CD44. J. Immunol. 147:2493-2498.
36. Naujokas, M.F., M. Morin, M.S. Anderson, M. Peterson, and J. Miller. 1993. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell response by interaction with CD44. Cell. 74:257-265.
37. Yang, B., B.L. Yang, R.C. Savanic, and E.A. Tueley. 1994. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAM. CD44, and link protein. EMBO (Eur. Mol. Biol. Organ.) J. 13:286-296.
38. Pure, E., R.L. Camp, D. Peritt, R.A. Panettieri, Jr., A.L. Lazaar, and S. Nayak. 1995. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 181:55-62.
39. Lokeshar, V.B., N. Fregien, and L.Y. Bourguignon. 1994. Ankyrin-binding domain of CD44 (gp85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol. 126:1099-1109.
40. Hathcock, K.S., H. Hirano, S. Murakami, and R.J. Hodes. 1993. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid. J. Immunol. 151:6712-6722.
41. Jalkanen, S., and M. Jalkanen. 1992. Lymphocyte CD44 binds the CooH-terminal heparin-binding domain of fibronectin. J. Cell Biol. 116:817-825.
42. Wayner, E.A., and W.G. Carter. 1987. Identification of multiple cell adhesion receptor for collagen and fibronectin in human fibrosarcoma cells possessing unique a and b subunits. J. Cell Biol. 105:1873-1884.
43. Toyama-Sorimachi, N., H. Sorimachi, Y. Tobita, F. Kitamura, H. Yagita, K. Suzuki, and M. Miyasaka, 1995. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adhesion and activation. J. Biol. Chem. 270:7437-7444.
44. Naujokas, M.F., M. Morin, M.S. Anderson, M. Peterson, and J. Miller. 1993. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell response by interaction with CD44. Cell. 74:257-268.
45. Droll, A., S.T. Dougherty, R.K. Chin, J.F. Dirks, W.H. McBride, D.L. Cooper, and G.J. Dougherty. 1995. Adhesive interaction between alternatively spliced CD44 isoforms. J. Biol. Chem. 270:11567-11573.
46. Cayabyab, M., J.H. Philips, and L.L. Lanier. 1994. CD40 preferentially costimulates activation of CD4 T cells. J. Immunol. 152:1523-1531.
47. Shinde, S., Y. Wu, Y. Guo, Q.-T. Niu, J. Xu, I.S. Grewal, R.A. Flavell, and Y. Liu. 1996. CD40L is important for induction of but not response to, costimulatory activity: ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L. J. Immunol. In press.